← Back to IRWD

Ironwood Pharmaceuticals, Inc. - Class A Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 07/05/2026Dec 2025Filed 26/02/2026Sep 2025Filed 26/02/2026Jun 2025Filed 06/08/2026Mar 2025Filed 07/05/2026Dec 2024Filed 26/02/2026Sep 2024Filed 26/02/2026
$113$107$48$122$85$41$91$92
$51$41−$2.3$40$24−$37$2.3$3.6
$0.31$0.24−$0.01$0.23$0.14−$0.23$0.01$0.02
167167178177161160

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.